Vascular cognitive impairment and dementia: An early career researcher perspective

被引:17
作者
Silva, Narlon C. Boa Sorte [1 ]
Bracko, Oliver [2 ]
Nelson, Amy R. [3 ]
de Oliveira, Fabricio Ferreira [4 ]
Robison, Lisa S. [5 ]
Shaaban, C. Elizabeth [6 ]
Hainsworth, Atticus H. [7 ,8 ]
Price, Brittani R. [9 ,10 ]
机构
[1] Univ British Columbia, Fac Med, Djavad Mowafaghian Ctr Brain Hlth, Dept Phys Therapy, Vancouver, BC, Canada
[2] Univ Miami, Dept Biol, Coral Gables, FL USA
[3] Univ S Alabama, Dept Physiol & Cell Biol, Mobile, AL USA
[4] Fed Univ Sao Paulo UNIFESP, Escola Paulista Med, Sao Paulo, Brazil
[5] Nova Southeastern Univ, Dept Psychol & Neurosci, Ft Lauderdale, FL USA
[6] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA
[7] St Georges Univ London, Mol & Clin Sci Res Inst, London, England
[8] St Georges Univ Hosp NHS Fdn Trust London, Dept Neurol, London, England
[9] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA
[10] Life Mol Imaging GmbH, 75 State St,Floor 1, Boston, MA 01209 USA
基金
巴西圣保罗研究基金会; 美国国家卫生研究院; 加拿大健康研究院;
关键词
early career researcher; vascular cognitive impairment; vascular dementia; VCID; SMALL VESSEL DISEASE; BLOOD-BRAIN-BARRIER; WHITE-MATTER INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; RAT MODEL; NEUROVASCULAR DYSFUNCTION; AEROBIC EXERCISE; OLDER-ADULTS; MOUSE MODEL;
D O I
10.1002/dad2.12310
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The field of vascular contributions to cognitive impairment and dementia (VCID) is evolving rapidly. Research in VCID encompasses topics aiming to understand, prevent, and treat the detrimental effects of vascular disease burden in the human brain. In this perspective piece, early career researchers (ECRs) in the field provide an overview of VCID, discuss past and present efforts, and highlight priorities for future research. We emphasize the following critical points as the field progresses: (a) consolidate existing neuroimaging and fluid biomarkers, and establish their utility for pharmacological and non-pharmacological interventions; (b) develop new biomarkers, and new non-clinical models that better recapitulate vascular pathologies; (c) amplify access to emerging biomarker and imaging techniques; (d) validate findings from previous investigations in diverse populations, including those at higher risk of cognitive impairment (e.g., Black, Hispanic, and Indigenous populations); and (e) conduct randomized controlled trials within diverse populations with well-characterized vascular pathologies emphasizing clinically meaningful outcomes.
引用
收藏
页数:13
相关论文
共 128 条
  • [1] Androgens' effects on cerebrovascular function in health and disease
    Abi-Ghanem, Charly
    Robison, Lisa S.
    Zuloaga, Kristen L.
    [J]. BIOLOGY OF SEX DIFFERENCES, 2020, 11 (01)
  • [2] Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis
    Ackley, Sarah F.
    Zimmerman, Scott C.
    Brenowitz, Willa D.
    Tchetgen, Eric J. Tchetgen
    Gold, Audra L.
    Manly, Jennifer J.
    Mayeda, Elizabeth Rose
    Filshtein, Teresa J.
    Power, Melinda C.
    Elahi, Fanny M.
    Brickman, Adam M.
    Glymour, M. Maria
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [3] White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
    Alber, Jessica
    Alladi, Suvarna
    Bae, Hee-Joon
    Barton, David A.
    Beckett, Laurel A.
    Bell, Joanne M.
    Berman, Sara E.
    Biessels, Geert Jan
    Black, Sandra E.
    Bos, Isabelle
    Bowman, Gene L.
    Brai, Emanuele
    Brickman, Adam M.
    Callahan, Brandy L.
    Corriveau, Roderick A.
    Fossati, Silvia
    Gottesman, Rebecca F.
    Gustafson, Deborah R.
    Hachinski, Vladimir
    Hayden, Kathleen M.
    Helman, Alex M.
    Hughes, Timothy M.
    Isaacs, Jeremy D.
    Jefferson, Angela L.
    Johnson, Sterling C.
    Kapasi, Alifiya
    Kern, Silke
    Kwon, Jay C.
    Kukolja, Juraj
    Lee, Athene
    Lockhart, Samuel N.
    Murray, Anne
    Osborn, Katie E.
    Power, Melinda C.
    Price, Brittani R.
    Rhodius-Meester, Hanneke F. M.
    Rondeau, Jacqueline A.
    Rosen, Allyson C.
    Rosene, Douglas L.
    Schneider, Julie A.
    Scholtzova, Henrieta
    Shaaban, C. Elizabeth
    Silva, Narlon C. B. S.
    Snyder, Heather M.
    Swardfager, Walter
    Troen, Aron M.
    van Veluw, Susanne J.
    Vemuri, Prashanthi
    Wallin, Anders
    Wellington, Cheryl
    [J]. ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 107 - 117
  • [4] Vascular and neuronal hypertensive brain damage: Protective effect of treatment with nicardipine
    Amenta, F
    Strocchi, P
    Sabbatini, M
    [J]. JOURNAL OF HYPERTENSION, 1996, 14 : S29 - S35
  • [5] 2020 Alzheimer's disease facts and figures
    不详
    [J]. ALZHEIMERS & DEMENTIA, 2020, 16 (03) : 391 - 460
  • [6] [Anonymous], 2021, FDA GRANTS ACC APPR
  • [7] [Anonymous], 1979, BELM REP ETH PRINC G
  • [8] Concomitant vascular and neurodegenerative pathologies double the risk of dementia
    Azarpazhooh, Mahmoud Reza
    Avan, Abolfazl
    Cipriano, Lauren E.
    Munoz, David G.
    Sposato, Luciano A.
    Hachinski, Vladimir
    [J]. ALZHEIMERS & DEMENTIA, 2018, 14 (02) : 148 - 156
  • [9] Baker L., 2018, J PREV ALZHEIMERS DI, V5, pS34
  • [10] Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial
    Barha, Cindy K.
    Hsiung, Ging-Yuek R.
    Best, John R.
    Davis, Jennifer C.
    Eng, Janice J.
    Jacova, Claudia
    Lee, Philip E.
    Munkacsy, Michelle
    Cheung, Winnie
    Liu-Ambrose, Teresa
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (04) : 1397 - 1410